Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Integumen, later rebranded as DeepVerge, was a life sciences company focused on the development and commercialization of technology for the skin care, pharmaceutical, and environmental sectors. The company's core platform, Labskin, provided a laboratory-grown human skin equivalent used for testing the impact of cosmetic and pharmaceutical products on the skin microbiome without animal testing. Following its rebranding to DeepVerge, the company expanded into environmental diagnostics, utilizing AI-driven sensors for real-time detection of pathogens like SARS-CoV-2 in wastewater. Despite initial commercial traction, the company faced significant financial difficulties and entered into a restructuring process, eventually leading to the cessation of its primary operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ITX International Equity.